Forecast: Systemic Hormonal Preparations Use (Excluding Sex Hormones and Insulins) in Canada

The forecast for systemic hormonal preparations use in Canada, excluding sex hormones and insulins, shows a gradual decline from 2024 to 2028. The usage rate decreases steadily from 41.2 units in 2024 to 40.4 units by 2028. The year-on-year variation indicates a slight decline annually, implying a slow but consistent reduction in the dosage rate per thousand persons per day over this period. Given these values, the compound annual growth rate (CAGR) reflects a modest negative trend, suggesting an overall downtrend in usage over the five years.

Trends to watch include advancements in alternative therapies and changes in medical guidelines, which may further impact hormonal preparation usage. Additionally, demographic shifts and healthcare policy changes could alter future demand. Monitoring these factors will be crucial in understanding the evolving landscape of hormonal medication consumption.